|Articles|August 2, 2016

SAB Proven More Fatal in Women Than Men

Author(s)Kristi Rosa

A new study has confirmed that significantly more women than men diagnosed with Staphylococcus aureus bacteraemia will die within 30 days of acquiring the infection.

Staphylococcus aureus is a major cause of bacteraemia, and compared with other pathogens, S. aureus bacteremia holds a higher risk of morbidity and mortality. Doctors worldwide have suspected that S. aureus bacteraemia found in women would lead to a worse outcome than the same bacteraemia found in men, but evidence to establish this gender difference had not yet been established, until now. A study published in the journal of Clinical Microbiology and Infection confirms that significantly more women than men who are diagnosed with Staphylococcus aureus bacteraemia (SAB) will die within 30 days.

According to an article by the Centers for Disease Control and Prevention (CDC), SAB is common and continues to be an increasing problem worldwide. Death rates remain high, even with the aid of antimicrobial drug treatment, mainly due to a consistent increase in antimicrobial drug resistance in S. aureus. Despite the fact that S. aureus remains a common cause of bloodstream infections, many of these infections are healthcare associated, and according to the CDC, that means that they are “potentially preventable.”

Researchers from Spain and Denmark used population-based medical registers in northern Denmark from 2000 to 2011 to conduct their study of adult patients with SAB. Using the Kaplan-Meier method, the researchers analyzed data on 2,638 SAB-diagnosed patients, and estimated the thirty-day mortality for both male and female patients with SAB.

The study found that within the first 30 days, 29% of the women had died compared to 22% of the men, making women 1.3 times more likely to die within a month of contracting SAB.

Jesper Smit, PhD, Aaalborg University Hospital, one of the study’s authors, noted in a news release by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), that the gender and fatality link could be witnessed across all age groups and the impact of gender was most pronounced in women who were diabetic or who were diagnosed with chronic pulmonary disease or cancer. However, researchers did not find a link between gender and infective endocarditis, infection of the inner lining of the heart, and osteomyelitis, infection of the bone, two common complications of SAB.

When speaking on further implications of the study, Smit said, “Although we now know that women in this situation are at a higher risk of death compared to men, we do not yet understand why. Further studies are needed to uncover the cellular and molecular mechanisms but the information we have generated should aid clinical decision making by helping to define which patients are most vulnerable.”

Based on their findings, the researchers of the study recommend that gender should be considered as a key element in the triage and risk stratification of SAB patients.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.